ArticleImmunity, inflammation and disease2026
Association of C-Reactive Protein-Triglyceride Glucose Index and TyG Index With Prehypertension and Hypertension.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the associations of the C-reactive protein-triglyceride glucose index (CTI) and the triglyceride-glucose (TyG) index with prehypertension and hypertension in a Chinese population aged 45 years and older. Based on blood pressure diagnostic criteria, 8389 eligible participants were categorized into three groups. In the multivariate logistic regression analysis, after adjusting for potential confounders (Model 2), individuals in the highest quartiles (Q4) of both indices exhibited a significantly increased risk of hypertension compared to those in the lowest quartiles (Q1). Specifically, the adjusted odds ratios (ORs) for Q4 were 1.592 (95% CI: 1.354-1.872) for the TyG index and 1.588 (95% CI: 1.356-1.860) for CTI. A similar independent association was observed for prehypertension. Notably, the CTI demonstrated an enhanced responsiveness in identifying hypertension at lower exposure levels, maintaining a significant association in the second quartile (Q2 OR: 1.201, 95% CI: 1.034-1.395). Furthermore, RCS analysis revealed a more pronounced non-linear dose-response relationship for CTI (P-non-linear < 0.001) than for TyG (P-non-linear = 0.045). Both CTI and the TyG index are independent indicators of prehypertension and hypertension in middle-aged and elderly Chinese adults. Although their standalone discriminatory power is modest (AUC ≈ 0.59), CTI may serve as a supplementary and cost-effective monitor for the early risk stratification of hypertension, given its responsiveness to non-linear risk transitions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.